2020 Annual Meeting | C117 - Pregnancy and Breastfeeding in Multiple Sclerosis

Date Monday 04/27/20

Time 03:30 PM - 05:30 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Megan Hyland, MD

Topic(s) Multiple Sclerosis

Learning Objectives Participants should be able to address a range of pre-conception topics with MS patients, discuss the current evidence regarding pregnancy-related relapse risks, recommend DMT options for MS patients from conception through postpartum period, identify MS patients who would most benefit from specialty care (i.e., MS centers, perinatology), and make evidence-based recommendations regarding breastfeeding for MS patients.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
03:30 PM - 03:40 PM	Introduction	Introduction of Course and Speakers Megan Hyland, MD
03:40 PM - 04:00 PM	Speaker	Fertility and Pregnancy Related Relapse Rates in MS Myla D. Goldman, MD, MSc, FAAN
04:00 PM - 04:20 PM	Speaker	Use/Safety of DMTs During Pregnancy Megan Hyland, MD
04:20 PM - 04:50 PM	Discussion	MS Disease Modifying Therapy Use in Pregnancy Cases
04:50 PM - 05:10 PM	Speaker	Breastfeeding Considerations in MS Jessica F. Robb, MD
05:10 PM - 05:30 PM	Q&A	Questions and Answers

Faculty Disclosures
Megan Hyland, MD	The institution of Dr. Hyland has received research support from Biogen. The institution of Dr. Hyland has received research support from PCORI.
Jessica F. Robb, MD	No disclosure on file
Myla D. Goldman, MD, MSc, FAAN	Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Seronon. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen, IDEC. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genzyme. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Goldman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ADAMAS. Dr. Goldman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis Pharmceuticals. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Greenwich Biosciences. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk. Dr. Goldman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics Ltd., .

��ɫ��

��ɫ��